Globe Life Financial Statements (GL)

Globe Lifesmart-lab.ru   FY2025Q3 FY2025Q4 FY2026Q1 FY2026Q2 FY2026Q2   LTM ?
Report date 05.11.2025 25.02.2026 07.05.2026 22.07.2026 05.08.2026   07.05.2026
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 1 513 1 524 1 560 1 600 1 600   6 078
Operating Income, bln rub 477.1 356.3 368.1 -629.6 -629.6   1 515
EBITDA, bln rub ? 513.2 379.3 368.1 -629.6 -629.6   1 609
Net profit, bln rub ? 387.8 266.0 270.5 287.7 287.7   1 177
OCF, bln rub ? 306.0 350.6 420.9 0.000 314.1   1 385
CAPEX, bln rub ? 97.3 20.5 24.9 0.000 16.5   155.6
FCF, bln rub ? 208.7 330.1 396.0 0.000 297.6   1 230
Dividend payout, bln rub 21.9 21.7 21.4 0.000 25.7   87.3
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 5.64% 8.15% 7.90% 0.00% 8.93%   7.41%
OPEX, bln rub 147.7 106.4 401.9 174.4 174.4   799.1
Cost of production, bln rub 888.2 1 061 789.6 2 404 2 404   3 764
R&D, bln rub 0.000 0.000 0.000 0.000 0.000   0.000
Interest expenses, bln rub 36.1 35.2 34.0 36.1 36.1   140.2
Assets, bln rub 30 528 30 814 30 966 0.000 31 563   30 966
Net Assets, bln rub ? 5 689 5 975 6 085 6 085 6 156   6 085
Debt, bln rub 2 714 2 625 2 779 0.000 2 943   2 779
Cash, bln rub 18 162 18 049 439.0 0.000 455.4   439.0
Net debt, bln rub -15 448 -15 423 2 340 0.00 2 488   2 340
Ordinary share price, rub 143.0 139.9 139.2 178.7 178.7   139.2
Number of ordinary shares, mln 82.0 80.9 78.4 78.4 78.4   78.4
Market cap, bln rub 11 726 11 308 10 913 14 011 14 011   10 913
EV, bln rub ? -3 722 -4 115 13 252 14 011 16 499   13 252
Book value, bln rub -1 674 -1 515 5 594 6 085 5 665   5 594
EPS, rub ? 4.73 3.29 3.45 3.67 3.67   15.0
FCF/share, rub 2.54 4.08 5.05 0.00 3.79   15.7
BV/share, rub -20.4 -18.7 71.3 77.6 72.2   71.3
EBITDA margin, % ? 33.9% 24.9% 23.6% -39.4% -39.4%   26.5%
Net margin, % ? 25.6% 17.5% 17.3% 18.0% 18.0%   19.4%
FCF yield, % ? 10.6% 11.1% 11.3% 6.67% 8.80%   11.3%
ROE, % ? 20.2% 19.4% 19.3% 19.9% 19.7%   19.3%
ROA, % ? 3.77% 3.77% 3.80% 3.84%   3.80%
P/E ? 10.2 9.74 9.27 11.6 11.6   9.27
P/FCF 9.41 9.02 8.87 15.0 11.4   8.87
P/S ? 1.97 1.89 1.80 2.26 2.26   1.80
P/BV ? -7.01 -7.46 1.95 2.30 2.47   1.95
EV/EBITDA ? -2.39 -2.59 8.24 22.2 26.1   8.24
Debt/EBITDA -9.90 -9.69 1.45 0.00 3.94   1.45
R&D/CAPEX, % 0.00% 0.00% 0.00% 0.00%   0.00%
CAPEX/Revenue, % 6.43% 1.35% 1.60% 0.00% 1.03%   2.56%
Globe Life shareholders